We are pleased to announce the election results, and to both congratulate and extend a warm welcome to our new officers and members of our Advisory Board/Governing Body. Over 56% of eligible WARMTH Members took part in the election.
Based on the election results and Advisory Board appointments the 2016/17 WARMTH Leadership is as follows:
Suresh Srivastava, Phd, President Elect of WARMTH and SNMMI Nuclear Oncology Council Vice President contributed an article for the spring 2014 NOC Newsletter. The article traces the history of WARMTH from the beginning in 2002 to our Society's goals for our ICRT events which are 1) To carry out an evaluation of the current status of radiopharmaceutical therapy on global basis; 2) To help in the transfer of important information on the current trends in radiopharmaceutical therapy from developed to developing countries; 3) To publish technical document based on the proceedings; 4) To promote radiopharmaceutical therapy on a global scale, particularly in developing countries; and 5) To formulate strategy documents for promoting the practice of radiopharmaceutical therapy around the world.
To read the entire article click here.
Our very dear friend and colleague, Prof. Dr. Ajit Kumar Padhy, passed away suddenly on the 22nd of August 2013 after suffering from a massive heart attack.
Prof Padhy was a Senior Consultant in the Singapore General Hospital, Department of Nuclear Medicine & PET since September 2005. Prior to that, he was the Head of Nuclear Medicine, IAEA, in the Division oF Human Health from 1997 to 2004, and he was Faculty of Nuclear Medicine, AIIMS, New Delhi, India since the 1970’s.
The World Journal of Nuclear Medicine is a scientific journal published quarterly.
The purposes of the journal are as follows:
- To promote research in nuclear medicine globally and in the developing countries in particular
- To promote good practice in nuclear medicine
- To help the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and Nuclear Medicine Society Singapore (NMSS) in their pursuit for promoting nuclear medicine around the world.
Target Group: All Nuclear Medicine Professionals practicing nuclear medicine around the world Specialists belonging to various fields of nuclear medicine (Physicians, radiopharmacists, physicists, radioimmunoassayists, molecular biologists, etc.), technologists and nurses
End-users of nuclear medicine procedures: Surgeons, physicians, endocrinologists, radiologists, nephrologists, cardiologists, rheumatologists, etc Manufacturers of equipment and reagents relevant to nuclear medicine Atomic Energy Commissions, Governmental and administrative personnel relevant to nuclear medicine practice in the various countries.
Page 4 of 4